Since a schizophrenia drug, the first in decades with an innovative mechanism of action, gained US regulatory approval in September, some researchers have proclaimed a new era for psychiatric ...

Summary. Iloperidone is an atypical antipsychotic that recently received marketing approval from the Food and Drug Administration for the acute treatment of schizophrenia. Iloperidone is a pure ...

Antipsychotics commonly used in the treatment of schizophrenia target dopamine receptors ... Researchers have developed a new drug, dubbed LY2140023, which is converted to a selective agonist ...

has approved Cobenfy (xanomeline/trospium chloride), a new medication offering a novel approach to treating schizophrenia, ...

Schizophrenia is a serious mental illness that requires treatment with medication to lessen symptoms. But even if your symptoms go away, you'll need to stay on treatment to avoid a relapse.

Schizophrenia, which affects about 1% of Americans, impacts how a person thinks, feels and behaves. doidam10 - stock.adobe.com People who land in the ER for psychedelic use are at significantly ...